Marshall E. Kadin, MD

Professor, Dermatology

Marshall Kadin
(401) 456-2000

Other Positions

  • Roger Williams Medical Center

Education

  • Northwestern University, MD
  • Northwestern University, BA

Publications

  • Published on 9/1/2017

    Kadin ME, Glicksman CA. Commentary on: Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman. Aesthet Surg J. 2017 Sep 01; 37(8):NP88-NP89. PMID: 29036946.

    Read at: PubMed
  • Published on 7/1/2017

    Kadin ME, Morgan J, Xu H, Glicksman CA. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017 07 01; 37(7):771-775. PMID: 28402493.

    Read at: PubMed
  • Published on 6/5/2017

    Perera LP, Zhang M, Nakagawa M, Petrus MN, Maeda M, Kadin ME, Waldmann TA, Perera PY. Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. Am J Hematol. 2017 Sep; 92(9):892-901. PMID: 28543380.

    Read at: PubMed
  • Published on 4/18/2017

    Wang X, Dasari S, Nowakowski GS, Lazaridis KN, Wieben ED, Kadin ME, Feldman AL, Boddicker RL. Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma. Oncotarget. 2017 Apr 18; 8(16):26245-26255. PMID: 28412739.

    Read at: PubMed
  • Published on 3/29/2017

    Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proc Natl Acad Sci U S A. 2017 Apr 11; 114(15):3975-3980. PMID: 28356514.

    Read at: PubMed
  • Published on 3/23/2017

    Fan P, Nong L, Sun J, Liu X, Kadin ME, Li T, Tu P, Wang Y. Primary cutaneous anaplastic large cell lymphoma with intralymphatic involvement associated with chronic lymphedema. J Cutan Pathol. 2017 Mar 23. PMID: 28337783.

    Read at: PubMed
  • Published on 2/10/2017

    Maliniemi P, Laukkanen K, Väkevä L, Dettmer K, Lipsanen T, Jeskanen L, Bessede A, Oefner PJ, Kadin ME, Ranki A. Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas. Oncoimmunology. 2017; 6(3):e1273310. PMID: 28405495.

    Read at: PubMed
  • Published on 1/30/2017

    Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Hum Pathol. 2017 Jun; 64:19-27. PMID: 28153507.

    Read at: PubMed
  • Published on 11/19/2016

    Watanabe M, Nakano K, Kadin ME, Higashihara M, Watanabe T, Horie R. CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells. Am J Pathol. 2017 Jan; 187(1):163-175. PMID: 27870927.

    Read at: PubMed
  • Published on 7/13/2016

    Battistella M, Janin A, Jean-Louis F, Collomb C, Leboeuf C, Sicard H, Bonnafous C, Dujardin A, Ram-Wolff C, Kadin ME, Bensussan A, Bagot M, Michel L. KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol. 2016 Aug; 175(2):325-33. PMID: 27037558.

    Read at: PubMed

View 257 more publications: View full profile at BUMC

View all profiles